Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7487)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 28, 2015 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hauser P, Kern S. Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications. World J Hepatol 2015; 7(15): 1921-1935 [PMID: 26244067 DOI: 10.4254/wjh.v7.i15.1921] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i15/1921.htm |
| Number | Citing Articles |
| 1 |
Irene Pericot-Valverde, Moonseong Heo, Jiajing Niu, Lior Rennert, Brianna L. Norton, Matthew J. Akiyama, Julia Arnsten, Alain H. Litwin. Relationship between depressive symptoms and adherence to direct-acting antivirals: Implications for Hepatitis C treatment among people who inject drugs on medications for opioid use disorder. Drug and Alcohol Dependence 2022; 234: 109403 doi: 10.1016/j.drugalcdep.2022.109403
|
| 2 |
David Back, Pamela Belperio, Mark Bondin, Francesco Negro, Andrew H. Talal, Caroline Park, ZhenZhen Zhang, Brett Pinsky, Eric Crown, Federico J. Mensa, Fiona Marra. Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis. Journal of Viral Hepatitis 2019; 26(8): 951 doi: 10.1111/jvh.13110
|
| 3 |
Elizabeth N. Madva, Samuel I. Kohrman. Massachusetts General Hospital Comprehensive Clinical Psychiatry. 2025; : 472 doi: 10.1016/B978-0-443-11844-9.00042-4
|
| 4 |
Peter Hauser. Hepatitis C and Psychiatric and Substance Use Disorders Co-morbidities; Caring for People with Hepatitis C: Lessons from the Past that Inform Expectations in the Future. Open Medicine Journal 2016; 3(1): 49 doi: 10.2174/1874220301603010049
|
| 5 |
Luis Margusino‐Framiñán, Eva Bobadilla‐Pérez, Purificación Cid‐Silva, Alejandro Rodríguez‐Sotelo, Juan C. Yáñez‐Rubal, Álvaro Mena‐de‐Cea, Francisco Suárez‐López, Andrea Prieto‐Pérez, Víctor Giménez‐Arufe, Manuel Delgado‐Blanco, Ana I. Sanclaudio‐Luhia, Isabel Martín‐Herranz, Ángeles Castro‐Iglesias. Effectiveness and safety of direct‐acting antivirals in hepatitis C infected patients with mental disorders: Results in real clinical practice. Journal of Medical Virology 2020; 92(12): 3488 doi: 10.1002/jmv.25772
|
| 6 |
Regan Preston, Michael Christmass, Eric Lim, Shirley McGough, Karen Heslop. Diagnostic Overshadowing of Chronic Hepatitis C in People With Mental Health Conditions Who Inject Drugs: A Scoping Review. International Journal of Mental Health Nursing 2024; 33(6): 1840 doi: 10.1111/inm.13396
|
| 7 |
Elizabeth Chereji, Shira Kern, Bret Fuller, Benjamin J. Morasco, Alissa Phelps, Peter Hauser. Co-occurring Depression, Chronic Pain and Substance Use Disorders in People with Hepatitis C. Open Medicine Journal 2016; 3(1): 79 doi: 10.2174/1874220301603010079
|
| 8 |
Jonathan Shuter, Alain H. Litwin, Mark S. Sulkowski, Addi Feinstein, Avram Bursky-Tammam, Stephen Maslak, Andrea H. Weinberger, Hannah Esan, Kate S. Segal, Brianna Norton. Cigarette Smoking Behaviors and Beliefs in Persons Living With Hepatitis C. Nicotine & Tobacco Research 2016; : ntw212 doi: 10.1093/ntr/ntw212
|
| 9 |
Ellen C. Caniglia, Maria Khan, Kaoon Ban, R. Scott Braithwaite. Integrating Screening and Treatment of Unhealthy Alcohol Use and Depression with Screening and Treatment of Anxiety, Pain, and Other Substance Use Among People with HIV and Other High-Risk Persons. AIDS and Behavior 2021; 25(S3): 339 doi: 10.1007/s10461-021-03245-5
|
| 10 |
Mawuena Binka, Sofia Bartlett, Héctor A. Velásquez García, Maryam Darvishian, Dahn Jeong, Prince Adu, Maria Alvarez, Stanley Wong, Amanda Yu, Hasina Samji, Mel Krajden, Jason Wong, Naveed Z. Janjua. Impact of COVID‐19‐related public health measures on HCV testing in British Columbia, Canada: An interrupted time series analysis. Liver International 2021; 41(12): 2849 doi: 10.1111/liv.15074
|
| 11 |
Elizabeth Le, Grace Chee, Miki Kwan, Ramsey Cheung. Treating the Hardest to Treat: Reframing the Hospital Admission as an Opportunity to Initiate Hepatitis C Treatment. Digestive Diseases and Sciences 2022; 67(4): 1244 doi: 10.1007/s10620-021-06941-3
|
| 12 |
Hiroshi Okano, Takanori Takenaka, Hiroki Asakawa, Satomi Tsuruga, Hiroaki Kumazawa, Yoshiaki Isono, Hiroki Tanaka, Shimpei Matsusaki, Tomohiro Sase, Tomonori Saito, Katsumi Mukai, Akira Nishimura. Direct‑acting antiviral treatment is safe and effective for chronic HCV patients with psychiatric disorders. Experimental and Therapeutic Medicine 2023; 26(2) doi: 10.3892/etm.2023.12100
|
| 13 |
K.S. Hong, N.R. Kim, S.H. Song, G. Hong. Cycling of Dexmedetomidine May Prevent Delirium After Liver Transplantation. Transplantation Proceedings 2018; 50(4): 1080 doi: 10.1016/j.transproceed.2017.11.076
|